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Introduction
Cervical cancer is the second most common cancer in women
worldwide1 and the seventh in Japan with an incidence of 8,779
new cases and 2,481 deaths recorded in 2002. Screening for cervi-
cal cancer by cytology has reduced the incidence of invasive cervi-
cal cancer, however, the number of young patients with invasive
cervical cancer has recently been increased.2
Radical hysterectomy is a standardized surgical procedure for
patients with stage Ib-IIb cancer. In cases of advanced disease or
in the presence of risk factors such as lymph node metastasis,
parametrial invasion, and involved resection margins, additional
therapy with radiation or concurrent chemoradiation is useful.
However, since this therapy is complicated by side effects such as
bladder or bowel dysfunction and sexual dysfunction, single mo-
dality treatment is preferred to keep morbidity low. On the other
hand, a more radical treatment is necessary to improve overall sur-
vival in surgically treated patients with high risk factors.
Therefore, it is necessary to ascertain further prognostic factors to
improve the therapeutic outcome.3
Tumor size has been proposed as an important prognostic factor
in patients with cervical cancer by many authors.4-13 However, in-
formation on the measurement of tumor size or volume in these re-
ports was ill-defined. Only a few centers have subjected cervical
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The purpose of the present study was to evaluate the prognostic significance and relationship between tumor volume and microvessel den-
sity in squamous cell carcinoma of the uterine cervix. The estimated tumor volume (TV) in 57 patients (22 stage Ib, 18 stage IIa, and 17 stage
IIb) had radical hysterectomy was calculated on the assumption that the tumor mass was spheroid. The micro-vessel density (MVD) was evalu-
ated as the ratio of endothelial area immunoreactive to factor-VIII related antigen (von Willebrand factor) to whole image area measured by
computer-aided image analysis system. Tumor volume ranged from 0.1 to 41.0 cm3 (median 3.6 cm3) and MVD from 0.33 to 2.95 % (median
0.85 %). A significantly larger median TV was noted in women with positive pelvic node metastasis (6.3 vs 2.6 cm3, P=0.0228), parametrial in-
vasion (8.9 vs 0.8 cm3, P<0.0001), and postoperative irradiation (5.4 vs 0.6 cm3, P=0.0007). In contrast, these clinical parameters had no effect
on MVD. There was no correlation between TV and MVD. The overall survival rate at 5 years was 93.1% and 60.7% (P=0.0037) between
women with a TV of ≦4 cm3 and >4 cm3, respectively; and 96.2% and 61.3% (P=0.0022) between tissue specimens with a MVD of ≦0.8% and
>0.8%, respectively. A combined TV of >4 cm3 and MVD >0.8% further deteriorated 5 year survival rate (42.1% vs 94.7%, P<0.0001).
Multivariate analysis indicated TV and MVD as independent risk factor in this series (P=0.041, P=0.03, respectively). Our current findings sug-
gested that TV and MVD are independent prognostic factors in women with cervical carcinoma who underwent radical hysterectomy. These
prognostic factors may be clinically useful for the selection of high-risk patients who need extensive adjuvant therapy.
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cancers obtained at surgery to precise morphometric study and thus
can relate patient outcome to tumor size reliably. 7,9,10 Meanwhile
the growth of solid tumors beyond 2mm diameter depends on
tumor angiogenesis, which may also permit tumor progression and
metastasis.14,15 So far many studies have shown a statistically sig-
nificant relationship between increased intratumoral microvessel
density (MVD) and risk of metastasis and/or decreased survival of
patients with solid tumors including cervical cancer.16,17 While
some investigators have shown that MVD counts might be an inde-
pendent prognostic factor, whereas others have been unable to re-
produce those findings. These differences in findings on MVD
counts may be caused by variability in staining and counting of
microvessels.18 Furthermore studies are still limited on the relation-
ship between tumor size and MVD and their individual or com-
bined effect on the survival of women with cervical cancer.
Based on these reasons, we planned to evaluate the prognostic
significance of tumor volume and MVD in cervical squamous cell
carcinoma in comparison to other prognostic factors, and objec-
tively examined the relationship between these two factors.
Materials and Methods
Patients and Tissues
Fifty-seven patients with squamous cell carcinoma of the uterine
cervix were treated initially by radical hysterectomy from 1981 to
1990 at Nagasaki University Hospital. Clinical information was re-
viewed from the patients' medical records. Availability of adequate
tissue material and clinical follow-up data was the only criterion for
selection of patients. A fraction of these patients underwent adjuvant
radiotherapy when risk factors for recurrence such as lymph node
metastasis, parametrial invasion, deep cervical stromal invasion,
and vessel permeation were present. An external beam radiation
with a total dose of 50 Gy was applied for radiotherapy. All tumor
specimens were routinely formalin-fixed and paraffin-embedded.
Serial sections from each paraffin block having deepest invasive
lesion per tumor specimen were subjected to immunohistochemical
study.
Tumor Volume
Assuming the collected tumor as spheriod shape, the estimated
volume of the primary tumor was calculated retrospectively by the
approximation formula as shown in Figure 1. Briefly, the depth of
the deepest invasive lesion (a) in the vertical direction was consid-
ered as sum of both deepest lesion (x) and most superficial lesion
(y). The width (b) of the widest invasive lesion along the direction
of cervical canal was evaluated from all blocks (median 12, range
10-20) of each tumor and using both macroscopic and microscopic
samples. Finally, the tumor volume (TV) was calculated according
to the formula as shown below:
TV (cm3)=(4 /3)(a/2)2 (b/2)
Immunohistochemistry
Expression of factor VIII-related antigen (von Willebrand factor,
VWF) was examined with the labeled strepto-avidine biotin proce-
dure (LSAB kit, DAKO JAPAN Co., Ltd., Kyoto, Japan) in formalin
fixed paraffin-embedded tissue specimens. Four- m thick sections were
cut and mounted on silane-coated glass slides. After deparaffinization,
the sections were immersed in xylene and rehydrated through a series
of graded ethanol and were washed three times with phosphate-
buffered-saline (PBS, pH 7.2). The samples for VWF expression
were initially treated with 0.1% trypsin (DIFCO Laboratories,
Detroit, Michigan, USA) in tris-HCL buffer (pH 7.6) at 37℃ for
15 min. Slides were immersed in a 10mM citrate buffer (pH 6.0)
and then micro-waved (MC-T5, NEC Corp., Tokyo, Japan) for a
total of 10 min (90℃). Anti-human VWF antibody (clone F8/86,
code M0616; DAKO, A/S, Denmark) is a mouse monoclonal anti-
body and was used as a primary antibody (1:50 dilution) and incu-
bated for 3 hours at room temperature. The slides were subsequently
incubated with biotinylated second antibody for 10 min, followed
by incubation with avidin-peroxidase for 10 min and visualized
with NiSO4/CoCl2/3,3'-diaminobenzidine tetrahydrochloride (DAB,
Wako Pure Chemicals Industries, Ltd., Osaka, Japan) and hydrogen
peroxide for color appearance19. Finally, the tissue sections were
dehydrated with serial alcohols, cleared in xylene, and mounted
with cover slip.
Microvessel Density
Microvessel density (MVD) was evaluated quantitatively by
computer-aided image analysis system which was comprised of a
optical microscope (Nikon, Tokyo, Japan) with 3CCD color vision
camera module (Sony, Tokyo, Japan), high resolution image monitor
(Sony), Image Grabber 1.2 color video digitizer software (Neotech,
Ltd., London, UK) and Mac Scope 2.5.3 image analysis software
(Mitani Co., Ltd., Fukui, Japan). The staining of vessels in the
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Figure 1. The estimated volume of primary tumor was measured by for-
mula as mentioned here. The detail of tumor volume calculation is de-
scribed in the text. TV indicates tumor volume (cm3); 'a' denotes depth of
the tumor (x+y); 'b' denotes width of the tumor.
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stroma outside the tumors was used as an internal positive control.
Negative controls were sections incubated with PBS only without
the primary antibody. Because there was no counterstaining for
VWF, a serially sectioned slide stained with hematoxylin and eosin
(H & E) (Figure 2-a) was used as a map to identify vessels in VWF
immunostained slide and to accurately target areas of carcinoma
for analysis. Vessels were analyzed only in the area of invasive
carcinoma. Slides were scanned at x40 magnification to determine
3 to 6 highly vascularized areas or "hot spots", which indicates
area with higher neovascular potential.13,20,21 The one imaging total
area was 1.07 mm2 . The original color image was input into the
computer and converted to gray image (Figure 2-b), so vessels
were observed as dark gray lines. A binary image (Figure 2-c) was
generated by computing a single adaptive threshold that was
adopted from the staining intensity of area with internal positive
control. An optimum threshold level to demarcate distinction be-
tween microvessels and background was adjusted by a single op-
erator. MVD was measured automatically as the ratio (%) of VWF
immunostained endothelial area to the whole image area.
Statistical analysis
Association among patient characteristics, tumor volume and
microvessel density was tested by Mann-Whitney's U test or re-
gression analysis. Survival was estimated using Kaplan-Meyer
method, and comparison between study groups was performed
with log-rank test. Multivariate analysis was performed using
Cox's proportional hazard model. For all statistical analyses, the
Stat View system of personal computer was used and P<0.05 was
considered as statistically significant.
Results
Patients were classified according to the clinical staging of the
International Federation of Gynecology and Obstetrics (FIGO), 22
were stage Ib, 18 were stage IIa and 17 were stage IIb. The mean
age of the patients at surgery was 55.9 years (range 33-72 years).
The tumor was classified for histological types (35 large cell non-
keratinizing, 10 small cell non-keratinizing, 12 keratinizing). Pelvic
lymph nodes were positive in 19 patients. Parametrial invasion and
vessel permeation were seen in 34 patients and 20 patients, respec-
tively. Mean follow-up period was 66.0 ± 32.7 months, with a
range of 10.5-174.3 months. A summary of tumors collected after
radical hysterectomy is listed in Table 1.
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Figure 2. Hematoxylin and eosin staining (a); immunohistochemical stain-
ing for factor VIII-related antigen, von Willebrand factor (b); and staining
area ratio (1.45%) as calculated by image binarization (c) for sections of
cervical carcinoma. Magnification, x40.
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Tumor Volume and Microvessel Density
Tumor volume (TV) assessed in 57 patients with primary cervi-
cal carcinoma ranged from 0.1 to 41.0 cm3 (median 3.6 cm3), and
MVD ranged from 0.33 to 2.95 % (median 0.85 %). As shown in
Table 2, significantly larger median TV was noted in cases with
positive pelvic node metastasis (2.6 versus 6.3 cm3 , P=0.0228),
parametrial invasion (0.8 versus 8.9 cm3, P<0.0001) and postopera-
tive irradiation (0.6 versus 5.4 cm3, P=0.0007). In contrast, neither
of these clinical parameters had any impact on MVD. In this series
of 57 patients there was no significant correlation between TV and
MVD (Figure 3).
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Figure 3. Shows the relationship between microvessel density (MVD %)
and tumor volume (cm3) of 57 patients with primary cervical carcinoma.
No relationship was observed between them (r=0.134; P=0.325).





































































TV, tumor volume; MVD, microvessel density; NS, not significant.
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Log-Rank Analysis
Patients with small (≦4cm3) TV had a significant good progno-
sis when compared with patients with large TV (>4cm3) (Figure
4). Five-year overall estimated survival rates were 93.1 % versus
60.7 %, respectively (P=0.0037). Again, patients with less MVD
(≦0.8%) displayed a significant good prognosis when compared
to patients with higher MVD (>0.8%) (Figure 5). Five-year overall
estimated survival rates were 96.2 % versus 61.3 %, respectively
(P=0.0022). FIGO stage, pelvic lymph node status, parametrial in-
vasion, and vessel permeation had no significant impact on prog-
nosis of patients as evaluated by univariate analysis in this series.
Multivariate Analysis
A Cox's proportional hazards model for overall survival was car-
ried out incorporating FIGO stage, pelvic node status, TV, and
MVD (Table 3). Only variables with P values of <0.30 in the
univariate analysis (log-rank analysis) were included in the multi-
variate analysis. Tumor volume and MVD were the only independ-
ent prognostic factors by multivariate analysis (Table 3). Patients
with combined large TV (>4cm3) and high MVD (>0.8%) had the
poorest prognosis (Figure 6) when compared with other factors.
Five-year overall estimated survival rates were 42.1 % versus 94.7
% for combined small TV (<4cm3 ) and less MVD (<0.8%)
(P<0.0001).
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Figure 4. Overall estimated 5 years survival of 57 patients with primary
cervical carcinoma according to tumor volume (TV). Patients with a TV of
≦4cm3 had a good survival rate (93.1%) when compared with women hav-
ing a TV >4cm3 (60.7%) (P=0.0037).
Figure 5. Overall estimated 5 years survival of 57 patients with primary
cervical carcinoma according to microvessel density (MVD). Specimens of
patients with a MVD of <0.8% showed a significantly better survival
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Table 3. Univariate and multivariate analysis of tumors with Cox's proportional hazards model to predict prognostic factors in
patients with cervical carcinoma.
TV, tumor volume; MVD, microvessel density; CI , confidence interval.
a Only variables with P<0.30 in the univariate analysis are included in the multivariate analysis.
Shingo Moriyama et al.: Prognostic Factors in Cervical Cancer
Discussion
We demonstrated in our current study that estimated large tumor
volume and increased microvessel density were independent prog-
nostic factors to predict the survival of patients with carcinoma of
the uterine cervix when compared with a number of other clinical
parameters. This was confirmed by both univariate and multivari-
ate analysis together with estimation from life-time survival curve.
Median tumor volume (4cm3) was a significant prognostic indi-
cator to isolate high- risk patients in this series. Tumor diameter
has been proposed as a prognostic factor for survival of patients
with cervical carcinoma by many authors3-12 . It is postulated that
patients with early stage Ib carcinoma of the cervix may have a
survival of 90% or greater, while patients with stage Ib "bulky"
tumor may have no more than a 50 or 60% survival. These patients
have a poorer survival than some with stage II disease. In order to
adjust this gap in the prognosis of patients with same stage Ib dis-
ease, FIGO Congress in Montreal, the Gynecologic Oncology
Committee proposed some changes in the staging of cervical can-
cer. In 1995, a new International Federation of Gynecology and
Obstetrics (FIGO) staging system for carcinoma of the cervix was
published with a proposal to divide patients with stage Ib into two
separate subgroups based on tumor extension and diameter: Ib1,
tumor limited to the cervix and ≦4.0 cm diameter; and Ib2, tumor
limited to the cervix and >4 cm diameter. However, the FIGO
committee realized that this subdivision of stage Ib is a step trying
to further delineate a wide spectrum of disease so that hopefully
the best treatment modality may be ascertained.22
Based on these facts, it remains a concern of debate whether
clinical tumor size can be considered as an actually important pre-
dictor of survival or not. This issue is still unclear. Finan et al.23
showed that the FIGO staging system for Ib1 and Ib2 disease did
not have an independent impact on survival in surgically treated
patients. They said that disease stage acted only through nodal
status in its impact on survival. Rutledge et al. subsequently dem-
onstrated that the prognosis in stage Ib carcinoma was mostly in-
fluenced by the presence of lymphovascular space involvement
and depth of stromal invasion and not by tumor size.24 The reason
for this is that clinical estimation of tumor size is a poor surrogate
for the actual tumor volume, because measurement of tumor size
is not standardized and obviously varies between various investiga-
tors.9,10
Burghardt et al. demonstrated in a large series that tumor
volumetry of surgical specimens obtained at radical hysterectomy
permitted a more accurate assessment of therapeutic results in pa-
tients with cervical cancer than does the FIGO classification.9 In
parallel with this study, Trattner et al. has proposed that tumor vol-
ume calculated by assuming an ellipsoid using the area of the larg-
est pathological tumor specimens might provide important prog-
nostic information if lymph node status was not known or
histopathological stage could not be assessed.4 Our data supported
those two studies and it appears reasonable to speculate that tumor
volume, because of its 3-dimensional measurement, would relate
even better to prognosis than a linear tumor size in clinical prac-
tice.
Microvessel density (MVD), as measured by endothelial stained
area and expressed as percentage of the whole tissue area, was
found to be another independent prognostic factor for carcinoma of
the uterine cervix. In fact, we found that patients with high MVD
of more than 0.8 % had significantly worse overall 5 years survival
rate (62%) than those with low MVD (≦0.8 %) in this study. This
overall survival rate in patients with cervical cancer further dete-
riorated (61% to 42%) when high MVD was combined with a large
tumor volume.
Angiogenesis has been shown to be essential for the growth and
progression of malignant tumors.25 MVD and its influence on sur-
vival has been studied in squamous cell carcinoma of the cervix,
but the results of those studies were inconsistent and the prognostic
value of MVD was uncertain,26 probably because of difficulties in
quantifying vascularization. Several methods have been applied to
quantify tumor vascularity irrespective of the manner of highlighting
the blood vessels in tissue sections. These methods are vessel counts
per unit area, relative amount of vascular volume, intercapillary dis-
tance, and distance from tumor cells to the closest microvessel.15 An
evaluation of vascularization has been demonstrated using the
method by manually counting the number of immunohistochemically
stained capillaries. Because blood vessel is not uniform within
tumor, the most densely vascularized area (so-called "hot spot")
often is selected.14 Moreover it is necessary of distinguishing indi-
vidual vessels for counting. Thus it was pointed out that manual
counting was time consuming and the potential subjectivity made
results uncertain. On the other hand, Schoell et al. demonstrated
that image analysis system for measurement of MVD was useful in
ovarian carcinoma.27 This study described that method of com-
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Figure 6. Overall estimated 5 years survival of 57 patients with primary
cervical carcinoma according to combined tumor volume (TV) and
microvessel density (MVD). Tumor of patients with a TV of >4cm3 and
MVD of >0.8% displayed worse prognosis (42.1%) when compared with
those of <4cm3 TV and <0.8% MVD (94.7%) (P=<0.0001).
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puter-aided image analysis might overcome some of the subjectiv-
ity inherent in the manual counting of vessels and may improve the
ability to evaluate accurately the angiogenic potential in ovarian
carcinoma. Our current study also evaluated MVD using image
analysis system by measuring immunoreactive endothelial cells to
von Willebrand factor. We assume that this method would be more
objective to measure vascularity in a defined tumor area than that
of manual counting of immunoreactive capillaries.
We did not find any significant correlation between tumor vol-
ume and microvessel density in this study, even both TV and MVD
were independent prognostic factors for overall survival by multi-
variate analysis. This lack of association between TV and MVD is
unclear but can be explained as follows. Most tumors become
symptomatic and clinically detected only after neovascularization.
It should be emphasized, however, that switching to the angiogenic
phenotype dose not always result in a rapidly proliferating tumor.23
In cervical cancer, the onset of angiogenesis is an early event in
pre-malignant changes of the cervix due in part to enhanced ex-
pression of vascular endothelial growth factor by the abnormal epi-
thelium.28 Recently, soft tissue contrast of magnetic resonance im-
aging (MRI) enables clear delineation of tumors within the uterine
cervix using an endovaginal or endorectal technique. Tumor vol-
ume measurements obtained from such images correlate well with
volume measurements at histopathology and are valuable predic-
tors of outcome.29 Moreover evaluation of microvessel density by
dynamic enhanced MRI has been evaluated in a recent report.30
In conclusion, we reported here for the first time that tumor vol-
ume and microvessel densities are independent prognostic factors
to predict the survival of patients with cervical cancers who under-
went radical hysterectomy. These two prognostic factors may be
clinically useful for the selection of high-risk patients who need
extensive adjuvant therapy. Further clinical study is necessary re-
garding association between tumor volume or vascularity at radio-
logical image and that by histopathology in order to strengthen the
significance of our current findings at tissue level.
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